Lupin Receives Tentative Approval from U.S. FDA for Sugammadex Injection

MUMBAI, India and NAPLES, Fla., March 31, 2026 /PRNewswire/ -- Global pharma major, Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it has received tentative approval from the United States Food and Drug Administration (U.S....